Pharmaroth Labs Inc. (ROTH) 0.0100 $ROTH
PharmaRoth Labs, Inc. Announces New Distribution Agreement in China
Marketwire - Wed Jul 23, 7:45AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, announces a new Distribution Agreement in the country of China. The agreement is with Tianjin Leading Biotechnology Co., Ltd, a leading distributor of traditional Chinese Medicines and Therapies.
PharmaRoth Labs, Inc. Announces Retail and Wholesale Distribution Channels in Mexico
Marketwire - Mon Mar 24, 7:45AM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH) (PINKSHEETS: ROTH), the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, announced today the retail and wholesale distribution channels for sales of their proprietary drug in Mexico. These distributors have come through the Company's exclusive marketing partner, Marcas de Renombre (MDR). Sucanon(R) is being sold retail in Walmart, Farmacias Benavides, Farmacias del Ahorro and HEB. The wholesale distributor that supplies smaller retailers is NADRO.
PharmaRoth Labs, Inc. Announces Results From FDA Application
Marketwire - Mon Mar 17, 7:45AM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH) (PINKSHEETS: ROTH) the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, announced today the FDA's response concerning the Company's New Dietary Ingredient (NDI) Application, filed last March. The Company's treatment is derived from natural ingredients, which generally allows it to be considered a nutraceutical product. However, upon careful review, the FDA determined that the active ingredient in Sucanon(R) will not be classified under a nutraceutical designation, but will henceforth be considered an Investigational New Drug (IND).
PharmaRoth Labs Completes First Shipment With Mexican Distributor
Marketwire - Mon Aug 19, 3:16PM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH), the exclusive producer and marketer of Sucanon(R), an oral Type-II Diabetes treatment, announced that it has shipped the first order from their new Mexican distributor Marcas de Renombre.
PharmaRoth Labs Completes First Shipment with New Mexican Distributor
ACCESSWIRE - Mon Aug 19, 8:05AM CDT
Las Vegas, NV, August 19, 2013 - (Accesswire) - PharmaRoth Labs, Inc. (OTCPink: ROTH) the exclusive producer and marketer of Sucanon[R], an oral Type-II Diabetes treatment, announced that it has shipped the first order from their new Mexican distributor Marcas de Renombre.
PharmaRoth Labs Welcomes Two Respected Physicians to Board of Advisors
PR Newswire - Wed Jun 05, 7:30AM CDT
PharmaRoth Labs, Inc. (OTCPink: ROTH), the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, is pleased to introduce the two newest members of the Company's Board of Advisors, Dr. Jose Alberto Rojas Jimenez and Dr. Alberto Meraz Soria. Dr. Rojas Jimenez recently concluded a clinical trial of Sucanon® on 98 Hispanic pre-diabetic patients, and the findings of the study are to be presented at the European Association for the Study of Diabetes Annual Meeting in Barcelona, Spain on September 23-27, 2013.
PharmaRoth Labs Signs Definitive Distribution Agreement in Mexico
PR Newswire - Tue May 28, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH) the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, announced today that it has entered into a definitive agreement with Marcas de Renombre, S.A de C.V. granting Marcas exclusive rights for the commercialization and distribution of Sucanon® in Mexico. The agreement is for 50 years with annual sales increases conditional for continuance of exclusivity, with the first shipment anticipated in June.
PharmaRoth Labs, Inc. Announces New Distribution Agreement in China
Marketwire - Wed Jul 23, 7:45AM CDT
PharmaRoth Labs, Inc. (OTC PINK: ROTH), the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, announces a new Distribution Agreement in the country of China. The agreement is with Tianjin Leading Biotechnology Co., Ltd, a leading distributor of traditional Chinese Medicines and Therapies.
PharmaRoth Labs, Inc. Announces Retail and Wholesale Distribution Channels in Mexico
Marketwire - Mon Mar 24, 7:45AM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH) (PINKSHEETS: ROTH), the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, announced today the retail and wholesale distribution channels for sales of their proprietary drug in Mexico. These distributors have come through the Company's exclusive marketing partner, Marcas de Renombre (MDR). Sucanon(R) is being sold retail in Walmart, Farmacias Benavides, Farmacias del Ahorro and HEB. The wholesale distributor that supplies smaller retailers is NADRO.
PharmaRoth Labs, Inc. Announces Results From FDA Application
Marketwire - Mon Mar 17, 7:45AM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH) (PINKSHEETS: ROTH) the exclusive producer, marketer & distributor of Sucanon(R), an oral Type-II Diabetes treatment, announced today the FDA's response concerning the Company's New Dietary Ingredient (NDI) Application, filed last March. The Company's treatment is derived from natural ingredients, which generally allows it to be considered a nutraceutical product. However, upon careful review, the FDA determined that the active ingredient in Sucanon(R) will not be classified under a nutraceutical designation, but will henceforth be considered an Investigational New Drug (IND).
PharmaRoth Labs Completes First Shipment With Mexican Distributor
Marketwire - Mon Aug 19, 3:16PM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH), the exclusive producer and marketer of Sucanon(R), an oral Type-II Diabetes treatment, announced that it has shipped the first order from their new Mexican distributor Marcas de Renombre.
PharmaRoth Labs Completes First Shipment with New Mexican Distributor
ACCESSWIRE - Mon Aug 19, 8:05AM CDT
Las Vegas, NV, August 19, 2013 - (Accesswire) - PharmaRoth Labs, Inc. (OTCPink: ROTH) the exclusive producer and marketer of Sucanon[R], an oral Type-II Diabetes treatment, announced that it has shipped the first order from their new Mexican distributor Marcas de Renombre.
PharmaRoth Labs Welcomes Two Respected Physicians to Board of Advisors
PR Newswire - Wed Jun 05, 7:30AM CDT
PharmaRoth Labs, Inc. (OTCPink: ROTH), the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, is pleased to introduce the two newest members of the Company's Board of Advisors, Dr. Jose Alberto Rojas Jimenez and Dr. Alberto Meraz Soria. Dr. Rojas Jimenez recently concluded a clinical trial of Sucanon® on 98 Hispanic pre-diabetic patients, and the findings of the study are to be presented at the European Association for the Study of Diabetes Annual Meeting in Barcelona, Spain on September 23-27, 2013.
PharmaRoth Labs Signs Definitive Distribution Agreement in Mexico
PR Newswire - Tue May 28, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH) the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, announced today that it has entered into a definitive agreement with Marcas de Renombre, S.A de C.V. granting Marcas exclusive rights for the commercialization and distribution of Sucanon® in Mexico. The agreement is for 50 years with annual sales increases conditional for continuance of exclusivity, with the first shipment anticipated in June.
